2,490 results found

The Superior Court confirmed that non-French trademarks on store-front signage do not need to be accompanied by a descriptor of the nature of the business.

As we previously reported, the Ontario Court of Appeal affirmed the lower court's decision dismissing Apotex's claims against Eli Lilly under the Ontario and English Statutes of Monopolies, Trademarks Act...

Merck sought leave to appeal a decision of the Federal Court of Appeal (2021 FCA 224) affirming a Federal Court decision upholding Health Canada's refusal to add a patent relating to a formulation of Merck's KEYTRUDA...

On January 8, 2021, the Supreme Court of Canada denied leave to Janssen and Kennedy Trust (Docket No. 39099) with respect to the Federal Court

Mark Robbins and François Larose write for World Trademark Review's Country Correspondents - Canada section,

On December 7, 2017, the Federal Court of Appeal upheld Justice Simpson's decision to strike Alexion's pleadings challenging the constitutionality of the PMPRB regime:

INVEGA SUSTENNA (paliperidone palmitate): Janssen v Pharmascience.

As previously reported, the Federal Court of Appeal overturned the Federal Court's conclusion that Apotex failed to mitigate the loss it incurred as a result of Health Canada's tortious conduct...

The world of digital marketing & advertising is fast-paced and always evolving to adopt the latest technology and capitalize on pop culture trends and new media channels.

In October 2020, the Pharmaceutical Advertising Advisory Board (PAAB) released an advisory addressing references to "no sub" or "no substitution" in advertising materials.

On December 10, 2019, the parties to the Canada-United States-Mexico Agreement (commonly referred to as USMCA, or the new NAFTA) signed amendments to the Agreement.

On February 1, 2023, the Minister of Health announced the appointment of Thomas J. Digby as the new Chairperson for the Patented Medicine Prices Review Board (PMPRB)...

Principals Ainslie Parsons and Noel Courage, along with expert international coauthors, recently contributed to an article in The Patent Lawyer Magazine examining how plant breeders and biotechs can protect...

CADTH releases 2018-2021 Strategic Plan

In its Common Drug Review (CDR) Update – Issue 133 (with further details in Revisions to CADTH's Biosimilar and Resubmission Processes, Other Administrative Changes...

The Government of Canada has proposed An Act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts, which has passed first reading in the Senate.

On March 13, 2019, the Competition Bureau ("Bureau") published the final version of its updated Intellectual Property Enforcement Guidelines (IPEGs).

On December 18, 2023, the Minister of Health announced the creation of the Canadian Drug Agency. According to the announcement...